다비가트란
Dabigatran is a pharmaceutical compound that functions as an active metabolite of the prodrug dabigatran etexilate. It is used in the manufacturing of anticoagulant medications for the prevention of stroke and systemic embolism.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 211914-51-1
Dabigatran ethyl ester
Pharmaceutical intermediate for dabigatran
Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride
Pharmaceutical intermediate for anticoagulant
Prazaxa
active pharmaceutical ingredient
Asciminib hydrochloride
Active pharmaceutical ingredient
Calcitonin human
active pharmaceutical ingredient
(3ss)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol-d4; CB 7598-d4;
Active pharmaceutical ingredient
Dabigatran impurity P
Dabigatran impurity reference standard
Ethyl 3-[[[2-[[(4-cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionate
Pharmaceutical intermediate for dabigatran
3-[[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid
YBSJFWOBGCMAKL-UHFFFAOYSA-N
CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N